Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Christopher J. Sweeney, Silke Gillessen et al.|Nature Medicine|2022Cited by 241
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate CancerNatàlia Jiménez, Begoña Mellado|Frontiers in Oncology|2020Cited by 16